SNY and TBIO buttoned up the news this morning sending a bunch of other biotech stocks running higher. Now that this is out of the way, levels could be important for longs looking for "what's next" and the 236 Fib level seems to be that area to watch. It was an area that the volatile SNY stock settled above for weeks and now is an area it hasn't been able to...
There will most likely be a 25% to 35% drop in BNTX over a very short period of time.
If we gap down Tuesday then expect it to drop the whole day.
Reasons: Price and volume divergence, over-extesnion of price and emotions, demand imbalances are way lower, topping formations intra-day.
Looks like GALT is back hanging out around the 786 level again. This is where it was trading around before the last big spike. But there's also another level to keep track of which is the 200DMA. Now that GALT is below this level, the 200 might be another possible area of resistance. Given the post-market action on Friday (7/30), GALT managed to break above the...
DOUBLED $ATOS Target 5.69 for 46.27% (Actually I a little bit more than doubled here, but not by too much)
Next add level at 2.09
Or Double Position again at 1.48
@Dau30 Here is my new average after doubling this morning… and I have a small order open at 2.80 but I’m watching for 1.48. A WILD day, for sure...
-----
—
On the far right of the chart is my Average...
NTEC trying to break and hold above this 786 fib level ....AGAIN. It was a previous area of support leading up to the last sell-off but since breaking below it has remained a sticky level of resistance.
"Aside from the cannabis directive, the company has also built a stronger pipeline for things like cancer. In fact, late last month, a patent abstract from...
Had to go way back to find some levels to plot against and 2017 looks like it's the mark. The interesting part is that this 236 area has been an area of traffic in the past. Considering that PAVM failed to break and hold (for now) once again might reinforce that idea. Prior to reaching those highs, the stock tested this area a few more times but failed at every...
FXCM's BIOTECH basket is in the bullish area on the daily chart on the left. The basket is made up of equal weighting of 2% each in ABBV, AMGN, GILD, CELG and VRTX. A bullish cross of EMAs and stochastic potentially align short-term traders with the daily. If signals occur, movement of stochastic to 80 level and maintenance of that level increase chance of a...
As far as popular reversal patterns go, ascending triangles are no bottom of the barrel. Although I still am a new trader, I have been committed to the market for just over 1 year. With that said I have been watching LABD/LABU in proximity of market trends. When the overall market is bullish I trade LABU with success. When Market is bearish I trade LABD with...
The london area and some countries are ordering millions of body bags.
They are super bearish. At the bottom. As usual.
Covid is over. There were 2 deadly waves and there won't be a third.
I hope I'm not offending anyone too much. I know that to big brains going against the fear narrative - which changes everyday - makes you a conspiracy theorist that believes...
Good news and even better volume today. We should see this build a base around $10 - $12. Earnings on the 29th should be interesting.
VWAP rejected and momentum slowed down.
Long $IPA. There is no way big pharma doesn't like this play.
🟢 $ATOS Target 6.84 for 35.71%
This one was caught by support so I added… I’ll add again at support if it goes that way… And if it breaks below I’ll double at 3.24
-----
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
Numbers with an A are places that are a good...
I took the NURO chart out to 2019, which was the last time it traded around these levels. After plotting these fibs, wouldn't you know, the 236 and 382 lined up almost EXACTLY with today's action. The 382 could be an important level to watch as this was a prior area of "high traffic" and a support/resistance pivot in 2019. With volume surging, 382 fib line could...
All,
I think CEMI is due for a huge run here oversold massively on almost all timeframes like daily/weekly. This has been building up and end of pattern now. I'd either scale in or get OTM options but further out.
AEMD seems to like this range between the 786 and 618 fib lines. The 618 has long-been a point of resistance on the chart. Meanwhile, the last few days have seen it test the 786 level but hold both above it AND its 50DMA. No news today but focus on biotechs thanks to CYTK earlier could be a sympathy trigger at play. Also with the Delta varient becoming "a...
Fib Retracement on NRXP doesn't show much by way of "important levels" until you get to the 786 if you use that ATH for the top of your fib set-up. BUT if you look back on the chart, there's a pretty clear level right AT the area NRXP stock is trading at after this news. Around $12.70 was a previous area where the stock tested but didn't break below. Now, since...
CYTK put in a fresh high today which was rejected HARD almost immediately after. This came after the company announced positive topline results from 2 cohorts in its REDWOOD-HCM Phase 2 clinical trial of CK-3773274 (CK-274). This is the company’s investigational treatment targeting hypertrophic cardiomyopathy.
“The combined data from Cohorts 1 and 2 in...
All,
BSGM WW here. could drop a little further, but keep some alerts on it. One of my favorite sideways pattern could be full on trend reversal.
Cash to debt ratio: 62 (crazy good)
Enterprise val/Mkt cap: (0.073 - Undervalued by about 20%)
Float: 27M
All, ABCL in a pretty solid spot here imo. Definitely need conformation of bottom here, candle looks to be a reversal possibly. I would look at 17-20$ calls OTM longer term or leveraged stock position hold long with a very tight stop loss. Could drop one more level. Just watch, slap some alerts on it but ABCL definitely imo worth 20-22.
